157 related articles for article (PubMed ID: 9595136)
41. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
Chen H; Wu J; Xu D; Luo H; Daloze P
Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
[No Abstract] [Full Text] [Related]
42. C1-Inh and heparan sulfate can prevent discordant rejection.
Di Stefano R; Frosini F; Scavuzzo M; Ambrogi M; Fagiolini A; Ferrari M; Pelosi G; Mosca F
Transplant Proc; 1994 Jun; 26(3):1172-3. PubMed ID: 8029876
[No Abstract] [Full Text] [Related]
43. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation.
Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN
Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458
[No Abstract] [Full Text] [Related]
44. Late xenograft rejection: comparison between liver and heart xenografts under low-dose tacrolimus.
Molleví DG; Morell Ginestà M; Ribas Y; Mestre M; Vidal A; Serano T; Figueras J; Jaurrieta J
Transplant Proc; 2002 Feb; 34(1):111-2. PubMed ID: 11959212
[No Abstract] [Full Text] [Related]
45. Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting.
Cooper DK; Good AH; Ye Y; Koren E; Oriol R; Ippolito RM; Malcolm AJ; Neethling FA; Romano E; Zuhdi N
Transplant Proc; 1993 Feb; 25(1 Pt 1):377-8. PubMed ID: 8438342
[No Abstract] [Full Text] [Related]
46. Use of a novel CD11b/CD18 inhibitory agent in a C6-deficient rat to evaluate delayed xenograft rejection.
Johnson E; Leventhal J; Dalmasso A; Goswitz J; Simone P; Chen S; Moyle M; Matas A
Transplant Proc; 1996 Apr; 28(2):728. PubMed ID: 8623367
[No Abstract] [Full Text] [Related]
47. Protective effect of FK-506 in pig-to-rat islet xenotransplantation is abrogated by prednisolone.
Song Z; Wennberg L; Zhang J; Sundberg B; Bari S; Groth CG; Korsgren O
Transplant Proc; 2000 Aug; 32(5):1025. PubMed ID: 10936332
[No Abstract] [Full Text] [Related]
48. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
[No Abstract] [Full Text] [Related]
49. Prolongation of survival of heterotopic heart xenografts by antibody and complement suppression in primates.
Mieny CJ; Karusseit VO; Van den Bogaerde JB; Hasan RI; White DJ
Transplant Proc; 1994 Jun; 26(3):1073. PubMed ID: 8029834
[No Abstract] [Full Text] [Related]
50. FK 506: an effective immunosuppressant for islet xenotransplantation.
Tze WJ; Tai J; Cheung SS; Ricordi C; Starzl TE
Transplant Proc; 1992 Dec; 24(6):2849-50. PubMed ID: 1281577
[No Abstract] [Full Text] [Related]
51. Pig-to-primate cardiac xenotransplantation and cyclophosphamide therapy.
Waterworth PD; Cozzi E; Tolan MJ; Langford G; Braidley P; Chavez G; Dunning J; Wallwork J; White D
Transplant Proc; 1997; 29(1-2):899-900. PubMed ID: 9123578
[No Abstract] [Full Text] [Related]
52. Efficacy of the malononitrilamide X 920715 as compared with leflunomide in cardiac allo- and xenotransplantation in rats.
Lin Y; Segers C; Waer M
Transplant Proc; 1996 Dec; 28(6):3036. PubMed ID: 8962178
[No Abstract] [Full Text] [Related]
53. Immunosuppressive effects of leflunomide in a cardiac allograft model.
Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN
Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465
[No Abstract] [Full Text] [Related]
54. Effect of mycophenolate mofetil with and without anti-CD4 (GK1.5) on fetal islet iso-, allo-, and xenografts in NOD/Lt female mice.
Koulmanda M; Kovarik J; Mandel TE
Transplant Proc; 1997 Jun; 29(4):2161-2. PubMed ID: 9193571
[No Abstract] [Full Text] [Related]
55. Treatment strategies of hamster-to-rat cardiac xenotransplantation.
Steinbrüchel DA; Nielsen B; Kemp E
Transplant Proc; 1994 Apr; 26(2):1039-41. PubMed ID: 8171460
[No Abstract] [Full Text] [Related]
56. Cellular basis of immunologic tolerance following total bowel transplantation in rats. II. Dominant role of suppressor T cells in adoptive transfer of acquired tolerance to vascularized allografts.
Masaki Y; Oohara T; Shinomiya T; Kimura H
Transplant Proc; 1995 Apr; 27(2):1589-92. PubMed ID: 7536972
[No Abstract] [Full Text] [Related]
57. Co-stimulatory molecules in islet xenotransplantation: CTLA4Ig treatment in CD40 ligand-deficient mice.
Benda B; Ljunggren HG; Peach R; Sandberg JO; Korsgren O
Cell Transplant; 2002; 11(7):715-20. PubMed ID: 12518898
[TBL] [Abstract][Full Text] [Related]
58. Long-term xenograft survival by combination therapy of malononitrilamide MNA 715 with cyclosporine.
Schorlemmer HU; Kurrle R
Transplant Proc; 1997 Dec; 29(8):3501-4. PubMed ID: 9414811
[No Abstract] [Full Text] [Related]
59. Mode of action of 15-deoxyspergualin in xenografting islets of Langerhans.
Nakajima Y; Yoshimura A; Kanehiro H; Aomatsu Y; Nakano H
Transplant Proc; 1994 Jun; 26(3):1093-4. PubMed ID: 8029842
[No Abstract] [Full Text] [Related]
60. 15-Deoxyspergualin in experimental transplant models: a review.
Kaufman DB
Transplant Proc; 1996 Apr; 28(2):868-70. PubMed ID: 8623440
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
